GE Healthcare and Intel Expand Intel Health Guide Marketing Agreement to United Kingdom

GE HealthcareGE Healthcare, a unit of GE (NYSE:GE), and Intel Corporation (NASDAQ: INTC) have expanded their sales and marketing agreement for the Intel Health Guide to include the United Kingdom. GE Healthcare already markets the Intel Health Guide in the United States.

The Intel Health Guide is a care management tool designed for health care professionals who manage patients with chronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease and heart failure. GE Healthcare's capabilities in disease management, and its distribution reach in the healthcare sector in the UK will help drive understanding of the benefits of this innovative technology, which includes patients' self-monitoring of health status and a direct communications channel to healthcare professionals.

This announcement further expands GE Healthcare's Home Health business in the United Kingdom. Currently the company operates a successful home health business in the United States, providing technologies to help seniors live independently and patients with chronic diseases manage their conditions from their home. With 3,000 employees in the United Kingdom, GE Healthcare is a world class provider of technologies for patient monitoring and diagnosis of disease, and has provided services to the NHS and the U.K. private health sector for more than 30 years. GE Healthcare's Home Health business in the United Kingdom will be managed by Richard Rees-Davies.

The U.K. Department of Health estimates that in Great Britain up to 17.5 million adults and up to three-quarters of those over the age of 75 could be living with a chronic disease. By 2030, the department also estimates that the incidence of chronic disease in those over the age of 65 will more than double,(1) creating an enormous and increasing burden for society. With the dramatic increase of people with chronic conditions and an aging population, there is a need to extend care from the hospital to the home.

Both GE and Intel are currently active in patient monitoring and home health, with well-recognized brands and strong sector expertise:

  • GE QuietCareĂ’ is a remote passive activity and behavioural monitoring system for the elderly, alerting caregivers to changes that may signal potential health issues or emergency situations such as a fall or emerging health problem. It is used primarily in assisted living facilities across the United States. GE Healthcare also brings significant capabilities in the development of products for critical care patient monitoring, cardiac diagnostics, home respiratory care, and healthcare IT such as electronic medical records and clinical decisions support.
  • The IntelĂ’ Health Guide is a comprehensive personal health system combining an in-home patient device with an online interface to allow clinicians to monitor patients in their homes and manage care remotely. The Health Guide includes vital sign collection, patient reminders and communications tools such as video conferencing and alerts. Intel already has a number of pilot programs underway in the United Kingdom to assess how the Health Guide can improve care management models in the home.

"Both the Department of Health and the National Health Service are leading some very progressive policy development and pilot programs in this area, and we hope that our Home Health business and expanded agreement with Intel into the U.K. will contribute to that," said Agnes Berzsenyi, general manager of GE Healthcare's Home Health business. "The increasing cost and burden of chronic disease is a huge problem, but we believe new health technologies and new approaches to care will make a difference in the future. It's a perfect fit with GE's healthymagination initiative, which aims to develop innovations that improve access, increase quality and reduce the cost of healthcare."

Intel Digital Health Group's director of sales and marketing Mariah Scott said, "We believe that shifting non-urgent care from the hospital to the home through technologies such as the Intel Health Guide is central to achieving a more personalized and cost-effective health care system. Intel has been working with PCTs, Health Trusts, carer organizations and policy makers in the United Kingdom to support the adoption of innovation in U.K. healthcare delivery and on a number of telehealth pilot schemes. The collaboration with GE Healthcare in the United Kingdom will bring improved understanding of this type of technology to a wider audience and increase the rate of adoption for telehealth systems as a method to help address chronic care challenges and bring benefits to patients and the NHS."

Related news articles:

1. Improving chronic disease management, Department of Health, 2004.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com/quietcare

More information about the GE Healthcare and Intel Healthcare Alliance is available at www.ge.com/press/healthalliance.

About Intel
Intel (NASDAQ: INTC), the world leader in silicon innovation, develops technologies, products and initiatives to continually advance how people work and live. Additional information about Intel is available at www.intel.com/pressroom and blogs.intel.com. More information on Intel's Health Guide is available at www.intel.com/go/healthguide.

Intel is a trademark of Intel Corporation or its subsidiaries in the United States and other countries.

Most Popular Now

AI can Help Improve Emergency Room Admis…

Generative artificial intelligence (AI), such as GPT-4, can help predict whether an emergency room patient needs to be admitted to the hospital even with only minimal training on a limited...

Philips ePatch and AI Analytics Platform…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the successful nationwide rollout of its ambulatory cardiac monitoring service in Spain using its unique wearable ePatch...

Is 'Smart Health Tech' Solving…

Opinion Article by Dr. Paul Deffley, Chief Medical Officer, Alcidion. Where would you position the NHS in relation to other countries, when it comes to the adoption of innovative technologies to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Comprehensive Bibliographic Dataset Adva…

A groundbreaking study published in Health Data Science, a Science Partner Journal, introduces a curated bibliographic dataset that aims to revolutionize the landscape of Health Artificial Intelligence (AI) research. Led...

New AI Algorithm may Improve Autoimmune …

A new advanced artificial intelligence (AI) algorithm may lead to better - and earlier - predictions and novel therapies for autoimmune diseases, which involve the immune system mistakenly attacking their...

AI Health Coach Lowers Blood Pressure an…

A new study in JMIR Cardio, published by JMIR Publications, shows that a fully digital, artificial intelligence (AI)-driven lifestyle coaching program can effectively reduce blood pressure (BP) in adults with...

Will Generative AI Change the Way Univer…

Since the launch of ChatGPT 3 in November 2022, we've been abuzz with talk of artificial intelligence: is it an unprecedented opportunity, or will it rob everyone of jobs and...

New Deep Learning Model is 'Game Ch…

Research led by the University of Plymouth has shown that a new deep learning AI model can identify what happens and when during embryonic development, from video. Published in the Journal...

Huge NHS Cloud Deals Mean Tough Question…

Opinion Article by Chris Scarisbrick, Deputy Managing Director, Sectra. The largest public cloud projects to ever take place within the NHS are beginning. Regional procurements for public cloud hosted diagnostic imaging...

A Three-Point Plan for Digital Delivery

Sam Shah has seen health tech policy up-close and worries that little progress has been made over the past five-years. However, he has a plan for any health and social...

AI Tech should Augment Physician Decisio…

The use of artificial intelligence (AI) in clinical health care has the potential to transform health care delivery but it should not replace physician decision-making, says the American College of...